PhageNova Bio, Inc.
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
PhageNova Bio, Inc. is a biotechnology company that develops a gene-therapy-based platform combining bacteriophage targeting with adeno-associated virus gene expression for cancer and vaccine applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhageNova Bio, Inc. Comparables
Compare PhageNova Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siren Biotechnology | 82% | |
| LyseNTech | 72% | |
| Coastar Therapeutics | 72% |
PhageNova Bio, Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 252% MoM, from 351 to 1.2K.
PhageNova Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PhageNova Bio, Inc.'s valuation, stock price, and market status.
Is PhageNova Bio, Inc. a public or private company?
PhageNova Bio, Inc. is a private company.
What is the current stock price of PhageNova Bio, Inc.?
PhageNova Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks PhageNova Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhageNova Bio, Inc. worth (valuation)?
Valuation information for PhageNova Bio, Inc. is not publicly available.
Can I buy PhageNova Bio, Inc. stock?
PhageNova Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhageNova Bio, Inc.'s last funding round?
Funding round information for PhageNova Bio, Inc. is not publicly available.
Who are the main investors in PhageNova Bio, Inc.?
Investor information for PhageNova Bio, Inc. is not publicly disclosed.
Will PhageNova Bio, Inc. IPO soon?
No public IPO plans have been announced for PhageNova Bio, Inc..
How can I track PhageNova Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PhageNova Bio, Inc.'s shares on secondary markets.